BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3055516)

  • 1. Preliminary clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS).
    Bretan PN; Baldwin N; Novick AC; Ng TC; Majors A; Stowe N; Streem S; Steinmuller D; Go R; Meaney T
    Transplant Proc; 1988 Oct; 20(5):852-3. PubMed ID: 3055516
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS) in 40 recipient patients.
    Bretan PN; Baldwin N; Novick AC; Majors A; Easley K; Ng TC; Stowe N; Streem S; Steinmuller D; Rehm P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1266-7. PubMed ID: 2652418
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of renal viability for transplantation by high field 31P-NMR.
    Pomer S; Hull WE; Röhl L
    Transplant Proc; 1988 Oct; 20(5):899-901. PubMed ID: 3055528
    [No Abstract]   [Full Text] [Related]  

  • 4. Pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy. Clinical experience in 40 recipient patients.
    Bretan PN; Baldwin N; Novick AC; Majors A; Easley K; Ng T; Stowe N; Rehm P; Streem SB; Steinmuller DR
    Transplantation; 1989 Jul; 48(1):48-53. PubMed ID: 2665235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy for evaluation of renal function.
    Weiner MW; Adam WR
    Semin Urol; 1985 Feb; 3(1):34-42. PubMed ID: 3890058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnetic resonance, a means for anatomically reliable imaging and noninvasive metabolic studies of kidney transplants].
    Pomer S; Hull WE; Fichtner K; Möhring K; Staehler G
    Helv Chir Acta; 1992 Oct; 59(3):465-6. PubMed ID: 1464542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy.
    Bretan PN; Vigneron DB; James TL; Williams RD; Hricak H; Juenemann KP; Yen TS; Tanagho EA
    J Urol; 1986 Apr; 135(4):866-71. PubMed ID: 3514965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of in situ renal transplant viability by 31P-MRS: experimental study in canines.
    Bretan PN; Vigneron DB; Hricak H; Price DC; Yen TS; Luo JA; Tanagho EA; James TL
    Am Surg; 1993 Mar; 59(3):182-7. PubMed ID: 8386489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of renal viability by high-field phosphorus-31 magnetic resonance spectrometry.
    Pomer S; Hull WE; Röhl L; Möhring K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1268. PubMed ID: 2652419
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictive parameters for renal preservation.
    Santiago-Delpin EA; Toledo-Pereyra LH; Moberg AW; Callender CO; Buselmeier TJ; Van Loon P; Simmons RL; Najarian JS
    Trans Am Soc Artif Intern Organs; 1974; 20 B():550-5. PubMed ID: 4615412
    [No Abstract]   [Full Text] [Related]  

  • 11. Noninvasive pHi measurements of human tissue using 31P-NMR.
    Bore PJ; Chan L; Gadian DG; Radda GK; Ross BD; Styles P; Taylor DJ
    Kroc Found Ser; 1981; 15():527-35. PubMed ID: 6951956
    [No Abstract]   [Full Text] [Related]  

  • 12. A new disposable perfusion machine, nuclear magnetic resonance compatible, to test the marginal organs and the kidneys from non-heart-beating donors before transplantation.
    Buchs JB; Bühler L; Morel P
    Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):421-4. PubMed ID: 17669888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procurement and preservation of cadaver kidneys.
    Barry JM
    Urol Clin North Am; 1983 May; 10(2):205-16. PubMed ID: 6344384
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of myocardial ischemia and viability by 31P nuclear magnetic resonance spectroscopy].
    Mitsunami K; Yabe T; Kinoshita M
    Rinsho Byori; 1998 Apr; 46(4):348-53. PubMed ID: 9594625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ and tissue preservation for transplantation: monitoring by 31P nuclear magnetic resonance.
    Marshall V; Ross B; Smith M; Bartlett S; Freeman D
    Transplant Proc; 1985 Apr; 17(2):1693-6. PubMed ID: 3885507
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphorus-31 MRS of the kidney.
    Hricak H
    Invest Radiol; 1989 Dec; 24(12):993-6. PubMed ID: 2691445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The 31P nuclear magnetic resonance (NMR) study of the preserved kidneys. III. Renal viability evaluated with intracellular pH].
    Kunikata S
    Nihon Hinyokika Gakkai Zasshi; 1987 Mar; 78(3):391-6. PubMed ID: 3656841
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of viability of hepatic cell membrane after cold storage by 31P-NMR and 23Na-NMR spectroscopy.
    Orii T; Ohkohchi N; Satomi S; Taguchi Y; Mori S; Muira I
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1657-8. PubMed ID: 8442227
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of a new cardioplegic solution for long-term heart preservation: experimental study using 31P magnetic resonance spectroscopy and biochemical analyses.
    Bernard M; Caus T; Sciaky M; Monties JR; Cozzone PJ
    Transplant Proc; 1996 Feb; 28(1):48-9. PubMed ID: 8644318
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential of 31P magnetic resonance spectroscopy in monitoring the viability of human renal grafts stored in Euro-Collins perfusion solution.
    Kurková D; Herynek V; Gintelová J; Táborský P; Hájek M
    Physiol Res; 1995; 44(5):327-32. PubMed ID: 8869268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.